• COMPANY
    • Expertise
      • Mission
      • Technology
      • Case Studies
        • Adenosine Receptor (A2A)
        • ABC Transporter (BmrA)
        • Bacteriorhodopsin
        • Bcl-2 Associated Athanogene 3 (BAG3)
        • K-Cl co-transporter 2 (KCC2)
        • Influenza A – H1N1 vaccinal preparation
        • Influenza Matrix Protein 2 (M2)
        • Voltage-gated Sodium Channel (Nav1.7)
      • Track Record
    • About Us
    • CALIXAR’s Partners
    • History
    • Business Model
    • Media
      • Press Releases
      • Related News
      • Events
  • PIPELINE
    • Undisclosed Ion Channel
    • Undisclosed Receptor
    • A2A
    • MT1
    • AcrB
    • BmrA
    • KCC2
    • Vaccine Programs
      • HIV
      • Leptospirosis
      • Influenza
  • PRODUCTS
    • Purified Membrane Proteins
      • GPCRs
        • A2A
        • MT1
        • Orphan GPCR
      • Ion Channels
        • KCC2
        • M2
      • Transporters
        • AcrB
        • BmrA
      • Vaccine Programs
        • HIV
        • Leptospirosis
        • Influenza
        • Chickungunya
    • Reagents and Kits
      • Soft Proprietary Detergents
        • CALX8
        • DDG
        • DDTAC
        • DLAC
        • FLAC6
        • ODG
      • Soft Proprietary Stabilization Reagents
        • CALXCHOL
        • CALXGLUK
        • DDLAC
        • FTAC6
        • FTAC8
      • Crystallization Kits
        • C2B
  • SERVICES
    • Production
      • Expression
      • Isolation
    • Identification
      • Proteomic Studies
      • Target Identification
      • Ligand Identification
      • Understanding mechanism of action for targets or ligands
    • Structure Determination
      • Cryo EM studies
      • Crystallogenesis
      • Xray studies
      • 3D Structure Determination
    • Biochemical Assays
      • Structural Assays
      • Functional Assays
      • Stabilization Assays
  • APPLICATIONS
    • Drug Discovery
      • Deorphanization
      • Target Identification
      • Target Validation
      • High Throughput Screening (HTS)
      • Structure Based Drug Design (SBDD)
      • Fragment Based Drug Design (FBDD)
      • Structural Studies (Cryo EM, Xrays, etc)
    • Antibody Discovery
      • Phage Display
      • Yeast Display
      • Immunization
    • Vaccine Discovery
      • Antigen Discovery
      • Vaccine Formulation
      • Anti Bacterial Based Vaccine
      • Anti Viral Based Vaccine
      • Cell Based Vaccine
      • Subunit Antigen Vaccine
      • Split Virus Based Vaccine
    • Immunoassays
  • NEWS
  • CONTACT
  • Protein-Protein Interaction
  • Protein-Ligand Interaction
  • Aggregation Studies
  • Tools for avoiding aggregation
Menu
  • COMPANY
    • Expertise
      • Mission
      • Technology
      • Case Studies
        • Adenosine Receptor (A2A)
        • ABC Transporter (BmrA)
        • Bacteriorhodopsin
        • Bcl-2 Associated Athanogene 3 (BAG3)
        • K-Cl co-transporter 2 (KCC2)
        • Influenza A – H1N1 vaccinal preparation
        • Influenza Matrix Protein 2 (M2)
        • Voltage-gated Sodium Channel (Nav1.7)
      • Track Record
    • About Us
    • CALIXAR’s Partners
    • History
    • Business Model
    • Media
      • Press Releases
      • Related News
      • Events
  • PIPELINE
    • Undisclosed Ion Channel
    • Undisclosed Receptor
    • A2A
    • MT1
    • AcrB
    • BmrA
    • KCC2
    • Vaccine Programs
      • HIV
      • Leptospirosis
      • Influenza
  • PRODUCTS
    • Purified Membrane Proteins
      • GPCRs
        • A2A
        • MT1
        • Orphan GPCR
      • Ion Channels
        • KCC2
        • M2
      • Transporters
        • AcrB
        • BmrA
      • Vaccine Programs
        • HIV
        • Leptospirosis
        • Influenza
        • Chickungunya
    • Reagents and Kits
      • Soft Proprietary Detergents
        • CALX8
        • DDG
        • DDTAC
        • DLAC
        • FLAC6
        • ODG
      • Soft Proprietary Stabilization Reagents
        • CALXCHOL
        • CALXGLUK
        • DDLAC
        • FTAC6
        • FTAC8
      • Crystallization Kits
        • C2B
  • SERVICES
    • Production
      • Expression
      • Isolation
    • Identification
      • Proteomic Studies
      • Target Identification
      • Ligand Identification
      • Understanding mechanism of action for targets or ligands
    • Structure Determination
      • Cryo EM studies
      • Crystallogenesis
      • Xray studies
      • 3D Structure Determination
    • Biochemical Assays
      • Structural Assays
      • Functional Assays
      • Stabilization Assays
  • APPLICATIONS
    • Drug Discovery
      • Deorphanization
      • Target Identification
      • Target Validation
      • High Throughput Screening (HTS)
      • Structure Based Drug Design (SBDD)
      • Fragment Based Drug Design (FBDD)
      • Structural Studies (Cryo EM, Xrays, etc)
    • Antibody Discovery
      • Phage Display
      • Yeast Display
      • Immunization
    • Vaccine Discovery
      • Antigen Discovery
      • Vaccine Formulation
      • Anti Bacterial Based Vaccine
      • Anti Viral Based Vaccine
      • Cell Based Vaccine
      • Subunit Antigen Vaccine
      • Split Virus Based Vaccine
    • Immunoassays
  • NEWS
  • CONTACT
  • Protein-Protein Interaction
  • Protein-Ligand Interaction
  • Aggregation Studies
  • Tools for avoiding aggregation
Search
Close

CALIXAR's Membrane Protein Transporters

CALIXAR’s membrane protein transporters assist our clients to develop, improve, validate new molecules, and discover therapeutic antibodies via multi-drug resistance studies.

Home / Products / Purified Membrane Proteins / Transporters

AcrB - Membrane Protein Transporter

Use CALIXAR’s Acriflavine resistance Protein B (AcrB) to aid in the development, refinement, and validation of new molecules and therapeutic antibodies.

BmrA - Membrane Protein Transporter

Apply CALIXAR's unique Bacillus subtilis multidrug resistant ABC transporters (BmrA) as a powerful therapeutic target for multi-drug resistance studies.

Contact us

Secure and boost your discovery programs.

Starting from native material or recombinant systems, we succeed with all types of membrane proteins: GPCRs, Ions Channels, Transporters, Receptors and Viral Proteins.

  • Conformational antibody development
  • Vaccine development
  • High-throughput ligand screening
  • Structure-based drug discovery
  • Immunoassays
  • Deorphanization projects
  • Identification of relevant targets
  • Expression of full-length membrane proteins
  • Functional isolation and stabilization of targets

About

CALIXAR’s approach allows to preserve the original structure and function of membrane proteins (GPCRs, Ion Channels, Transporters, Receptors, Anchors and Viral Proteins) providing solutions for pharmaceutical industries, biotechnology companies and academic teams to develop conformational antibodies, formulate new vaccines, carry out Structure Based Drug Discovery and/or HTS assays.

Headquarters

  • Bâtiment Laennec
    60 avenue Rockefeller
    69008 Lyon - FRANCE
  • +33 481 076 460
  • contact(at)calixar.com

Links

Expertise

Company

Pipeline

Products

Services

Applications

Jobs

© 2020 Calixar. All rights reserved.

  • Legal notice
  • Sitemap
Linkedin-in
Youtube
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok